The objective of this study was first to evaluate the diagnostic performance of the urinary biomarker CHI3L1 for early detection of AKI stage ≥2 in adult critically ill patients, and then to compare this performance to that of NGAL, which was chosen as the reference urinary biomarker. Here, CHI3L1 is linked to acute kidney injury.